Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

aTyr Pharma, Inc. Common Stock (LIFE)

Biological Products, (no Disgnostic Substances)

https://www.atyrpharma.com

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

10240 SORRENTO VALLEY ROAD, SUITE 300
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/07/2015

Market Cap

131,120,702

Shares Outstanding

58,560,000

Weighted SO

58,560,061

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

MREO --.--%

TERN --.--%

PDSB --.--%

INZY --.--%

HOOK --.--%

XFOR --.--%

DAWN --.--%

ABOS --.--%

AMLX --.--%

Beta

1.1880

Last Div

0.0000

Range

1.0801-2.45

Chg

0.0500

Avg Vol

480976

Mkt Cap

131120702

Exch

NASDAQ

Country

US

Phone

858 731 8389

DCF Diff

1.7849

DCF

0.1151

Div Yield

0.0000

P/S

26.7430

EV Multiple

-2.4285

P/FV

1.4864

Div Yield %

0.0000

P/E

-2.3281

PEG

-0.0586

Payout

0.0000

Current Ratio

6.0652

Quick Ratio

5.4429

Cash Ratio

0.4261

DSO

184.3239

DIO

0.0000

Op Cycle

184.3239

DPO

648.0207

CCC

-463.6968

Gross Margin

0.4379

Op Margin

-11.9861

Pretax Margin

-10.9994

Net Margin

-10.9992

Eff Tax Rate

0.0184

ROA

-0.4762

ROE

-0.5683

ROCE

-0.6042

NI/EBT

1.0000

EBT/EBIT

0.9177

EBIT/Rev

-11.9861

Debt Ratio

0.1247

D/E

0.1672

LT Debt/Cap

0.1333

Total Debt/Cap

0.1433

Int Coverage

-70.2967

CF/Debt

-3.8943

Equity Multi

1.3408

Rec Turnover

1.9802

Pay Turnover

0.5633

Inv Turnover

0.0000

FA Turnover

0.3774

Asset Turnover

0.0433

OCF/Share

-0.8325

FCF/Share

-0.8777

Cash/Share

1.2787

OCF/Sales

-11.2199

FCF/OCF

1.0543

CF Coverage

-3.8943

ST Coverage

-48.4252

CapEx Coverage

-18.4230

Div&CapEx Cov

-18.4230

P/BV

1.4864

P/B

1.4864

P/S

26.7430

P/E

-2.3281

P/FCF

-2.2608

P/OCF

-2.2823

P/CF

-2.2823

PEG

-0.0586

P/S

26.7430

EV Multiple

-2.4285

P/FV

1.4864

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation